P15927 (RFA2_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 146.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Replication protein A 32 kDa subunit Short name=RP-A p32 Alternative name(s): Replication factor A protein 2 Short name=RF-A protein 2 Replication protein A 34 kDa subunit Short name=RP-A p34 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 270 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Required for DNA recombination, repair and replication. The activity of RP-A is mediated by single-stranded DNA binding and protein interactions. Required for the efficient recruitment of the DNA double-strand break repair factor RAD51 to chromatin in response to DNA damage. Ref.9 Ref.13 Ref.14 Ref.15 Functions as component of the alternative replication protein A complex (aRPA). aRPA binds single-stranded DNA and probably plays a role in DNA repair; it does not support chromosomal DNA replication and cell cycle progression through S-phase. In vitro, aRPA cannot promote efficient priming by DNA polymerase alpha but supports DNA polymerase delta synthesis in the presence of PCNA and replication factor C (RFC), the dual incision/excision reaction of nucleotide excision repair and RAD51-dependent strand exchange. Ref.9 Ref.13 Ref.14 Ref.15 |
| Subunit structure | Heterotrimer of 70, 32 and 14 kDa chains (canonical replication protein A complex). Component of the alternative replication protein A complex (aRPA) composed of RPA1, RPA3 and RPA4. The DNA-binding activity may reside exclusively on the 70 kDa subunit. Binds to SERTAD3/RBT1. Interacts with TIPIN. Directly interacts with PPP4R2, but not with SMEK2; this interaction is DNA damage-dependent and leads RPA2 dephosphorylation by PPP4C recruitment. Interacts with RAD51, preferentially when hyperphosphorylated. Directly interacts with RFWD3. Ref.7 Ref.10 Ref.11 Ref.13 Ref.15 Ref.18 Ref.19 |
| Subcellular location | Nucleus. Nucleus › PML body. Note: Also present in PML nuclear bodies. Redistributes to discrete nuclear foci upon DNA damage. Ref.8 Ref.15 Ref.18 Ref.19 |
| Post-translational modification | Phosphorylated in a cell-cycle-dependent manner (from the S phase until mitosis). In response to DNA damage, recruited to DNA-repair nuclear foci, as a hypophosphorylated form. The necessary dephosphorylation step is catalyzed by PP4. Subsequent hyperphosphorylation, catalyzed by ATR, is required for RAD51 recruitment to chromatin and efficient DNA repair. Can be phosphorylated in vitro by PRKDC/DNA-PK in the presence of Ku and DNA, and by CDK1. Phosphorylation at Thr-21 depends upon RFWD3 presence. Ref.6 Ref.8 Ref.19 |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| GAPDH | P04406 | 2 | EBI-621404,EBI-354056 | |
| RPA1 | P27694 | 4 | EBI-621404,EBI-621389 | |
| RPA3 | P35244 | 3 | EBI-621404,EBI-621428 | |
| XPA | P23025 | 3 | EBI-621404,EBI-295222 |
Alternative products
| This entry describes 3 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: P15927-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: P15927-2) The sequence of this isoform differs from the canonical sequence as follows: 1-4: MWNS → MGRGDRNKRSIR | ||||||
| Note: No experimental confirmation available. | ||||||
| Isoform 3 (identifier: P15927-3) The sequence of this isoform differs from the canonical sequence as follows: 1-4: MWNS → MWNSNDGGAG...QALILLFKTG | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 270 | 270 | Replication protein A 32 kDa subunit | PRO_0000097270 | |||||||||||||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||||||||||||
| Region | 187 – 270 | 84 | Interaction with TIPIN By similarity | ||||||||||||||||||||||||||||||||||||||||||
| Compositional bias | 1 – 29 | 29 | Gly/Ser-rich | ||||||||||||||||||||||||||||||||||||||||||
| Compositional bias | 37 – 45 | 9 | Arg/Lys-rich (basic) | ||||||||||||||||||||||||||||||||||||||||||
| Compositional bias | 95 – 123 | 29 | Asp/Glu-rich (acidic) | ||||||||||||||||||||||||||||||||||||||||||
| Compositional bias | 127 – 145 | 19 | Arg/Lys-rich (basic) | ||||||||||||||||||||||||||||||||||||||||||
| Compositional bias | 247 – 270 | 24 | Asp/Glu-rich (acidic) | ||||||||||||||||||||||||||||||||||||||||||
Sites | |||||||||||||||||||||||||||||||||||||||||||||
| Site | 23 | 1 | Not phosphorylated Probable | ||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 1 | 1 | N-acetylmethionine Ref.6 Ref.16 | ||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 21 | 1 | Phosphothreonine; by PRKDC; in vitro Ref.6 Ref.19 | ||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 23 | 1 | Phosphoserine Ref.16 | ||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 29 | 1 | Phosphoserine; by CDK1; in vitro Ref.6 Ref.16 | ||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 33 | 1 | Phosphoserine; by PRKDC; in vitro Ref.6 | ||||||||||||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 1 – 4 | 4 | MWNS → MGRGDRNKRSIR in isoform 2. | VSP_017201 | |||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 1 – 4 | 4 | MWNS → MWNSNDGGAGWRRKRIAGGF SKRASLGSERRVVAGEEGRE RSWGVWGSPAGRRRGRLGRL GQCLKGRSLREPAGFSEAWD VAQALILLFKTG in isoform 3. | VSP_017202 | |||||||||||||||||||||||||||||||||||||||||
| Natural variant | 14 | 1 | Y → S. Ref.3 Corresponds to variant rs28988896 [ dbSNP | Ensembl ]. | VAR_023300 | |||||||||||||||||||||||||||||||||||||||||
| Natural variant | 15 | 1 | G → R. Ref.3 Corresponds to variant rs28988897 [ dbSNP | Ensembl ]. | VAR_023301 | |||||||||||||||||||||||||||||||||||||||||
| Natural variant | 203 | 1 | N → S. Ref.3 Corresponds to variant rs28904899 [ dbSNP | Ensembl ]. | VAR_023302 | |||||||||||||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 8 | 1 | S → D: Lower homologous recombination efficiency following DNA double strand break. Impaired DNA synthesis following DNA damage; when associated with D-33. No effect on cell-cycle progression, nor DNA synthesis in undamaged cells; when associated with D-23; D-29 and D-33. Impaired DNA double strand breaks repair; when associated with D-23; D-29 and D-33. Extended DNA damage-induced G2-M checkpoint; when associated with D-23; D-29 and D-33. Preferentially interacts with RAD51; when associated with D-23; D-29 and D-33. Ref.6 Ref.15 | ||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 23 | 1 | S → D: No effect on DNA synthesis following DNA damage; when associated with D-29. No effect on cell-cycle progression, nor DNA synthesis in undamaged cells; when associated with D-8; D-29 and D-33. Impaired DNA double strand breaks repair; when associated with D-8; D-29 and D-33. Extended DNA damage-induced G2-M checkpoint; when associated with D-8; D-29 and D-33. Preferentially interacts with RAD51; when associated with D-8; D-29 and D-33. Ref.15 | ||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 29 | 1 | S → A: Reduces phosphorylation by CDK1. Ref.6 Ref.15 | ||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 29 | 1 | S → D: No effect on DNA synthesis following DNA damage; when associated with D-23. No effect on cell-cycle progression, nor DNA synthesis in undamaged cells; when associated with D-8; D-23 and D-33. Impaired DNA double strand breaks repair; when associated with D-8; D-23 and D-33. Extended DNA damage-induced G2-M checkpoint; when associated with D-8; D-23 and D-33. Preferentially interacts with RAD51; when associated with D-8; D-23 and D-33. Ref.6 Ref.15 | ||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 33 | 1 | S → D: Lower homologous recombination efficiency following DNA double strand break. Impaired DNA synthesis following DNA damage; when associated with D-8. No effect on cell-cycle progression, nor DNA synthesis in undamaged cells; when associated with D-8; D-23 and D-29. Impaired DNA double strand breaks repair; when associated with D-8; D-23 and D-29. Extended DNA damage-induced G2-M checkpoint; when associated with D-8; D-23 and D-29. Preferentially interacts with RAD51; when associated with D-8; D-23 and D-29. Ref.15 | ||||||||||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 46 – 48 | 3 | |||||||||||||||||||||||||||||||||||||||||||
| Helix | 51 – 55 | 5 | |||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 58 – 62 | 5 | |||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 64 – 66 | 3 | |||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 69 – 71 | 3 | |||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 73 – 85 | 13 | |||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 87 – 95 | 9 | |||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 97 – 100 | 4 | |||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 102 – 107 | 6 | |||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 125 – 135 | 11 | |||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 138 – 148 | 11 | |||||||||||||||||||||||||||||||||||||||||||
| Helix | 153 – 171 | 19 | |||||||||||||||||||||||||||||||||||||||||||
| Helix | 207 – 218 | 12 | |||||||||||||||||||||||||||||||||||||||||||
| Turn | 222 – 224 | 3 | |||||||||||||||||||||||||||||||||||||||||||
| Helix | 227 – 233 | 7 | |||||||||||||||||||||||||||||||||||||||||||
| Helix | 239 – 251 | 13 | |||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 254 – 257 | 4 | |||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 263 – 268 | 6 | |||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "The primary structure of the 32-kDa subunit of human replication protein A." Erdile L.F., Wold M.S., Kelly T.J. J. Biol. Chem. 265:3177-3182(1990) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PARTIAL PROTEIN SEQUENCE. |
| [2] | "Cloning of human full open reading frames in Gateway(TM) system entry vector (pDONR201)." Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B. Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). |
| [3] | NIEHS SNPs program Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS SER-14; ARG-15 AND SER-203. |
| [4] | "The DNA sequence and biological annotation of human chromosome 1." Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K. Bentley D.R.Nature 441:315-321(2006) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Kidney, Lung and Muscle. |
| [6] | "Mapping of amino acid residues in the p34 subunit of human single-stranded DNA-binding protein phosphorylated by DNA-dependent protein kinase and Cdc2 kinase in vitro." Niu H., Erdjument-Bromage H., Pan Z.-Q., Lee S.-H., Tempst P., Hurwitz J. J. Biol. Chem. 272:12634-12641(1997) [PubMed] [Europe PMC] [Abstract] Cited for: ACETYLATION AT MET-1, PHOSPHORYLATION AT THR-21; SER-29 AND SER-33, MASS SPECTROMETRY, MUTAGENESIS OF SER-29. |
| [7] | "RBT1, a novel transcriptional co-activator, binds the second subunit of replication protein A." Cho J.M., Song D.J., Bergeron J., Benlimame N., Wold M.S., Alaoui-Jamali M.A. Nucleic Acids Res. 28:3478-3485(2000) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH SERTAD3. |
| [8] | "ATR kinase activity regulates the intranuclear translocation of ATR and RPA following ionizing radiation." Barr S.M., Leung C.G., Chang E.E., Cimprich K.A. Curr. Biol. 13:1047-1051(2003) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION, SUBCELLULAR LOCATION. |
| [9] | "Coordinated regulation of replication protein A activities by its subunits p14 and p32." Weisshart K., Pestryakov P., Smith R.W.P., Hartmann H., Kremmer E., Lavrik O., Nasheuer H.-P. J. Biol. Chem. 279:35368-35376(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [10] | "Mammalian TIMELESS and Tipin are evolutionarily conserved replication fork-associated factors." Gotter A.L., Suppa C., Emanuel B.S. J. Mol. Biol. 366:36-52(2007) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH TIPIN. |
| [11] | "The human Tim/Tipin complex coordinates an Intra-S checkpoint response to UV that slows replication fork displacement." Uensal-Kacmaz K., Chastain P.D., Qu P.-P., Minoo P., Cordeiro-Stone M., Sancar A., Kaufmann W.K. Mol. Cell. Biol. 27:3131-3142(2007) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH TIPIN. |
| [12] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Cervix carcinoma. |
| [13] | "An alternative form of replication protein a prevents viral replication in vitro." Mason A.C., Haring S.J., Pryor J.M., Staloch C.A., Gan T.F., Wold M.S. J. Biol. Chem. 284:5324-5331(2009) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION IN THE ARPA COMPLEX, FUNCTION OF THE ARPA COMPLEX. |
| [14] | "An alternative form of replication protein a expressed in normal human tissues supports DNA repair." Kemp M.G., Mason A.C., Carreira A., Reardon J.T., Haring S.J., Borgstahl G.E., Kowalczykowski S.C., Sancar A., Wold M.S. J. Biol. Chem. 285:4788-4797(2010) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION OF THE ARPA COMPLEX. |
| [15] | "A PP4 phosphatase complex dephosphorylates RPA2 to facilitate DNA repair via homologous recombination." Lee D.H., Pan Y., Kanner S., Sung P., Borowiec J.A., Chowdhury D. Nat. Struct. Mol. Biol. 17:365-372(2010) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH PPP4C; PPP4R2 AND RAD51, SUBCELLULAR LOCATION, MUTAGENESIS OF SER-8; SER-23; SER-29 AND SER-33. |
| [16] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23 AND SER-29, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [17] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [18] | "E3 ligase RFWD3 participates in replication checkpoint control." Gong Z., Chen J. J. Biol. Chem. 286:22308-22313(2011) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH RFWD3, SUBCELLULAR LOCATION. |
| [19] | "RING finger and WD repeat domain 3 (RFWD3) associates with replication protein A (RPA) and facilitates RPA-mediated DNA damage response." Liu S., Chu J., Yucer N., Leng M., Wang S.Y., Chen B.P., Hittelman W.N., Wang Y. J. Biol. Chem. 286:22314-22322(2011) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH RFWD3, SUBCELLULAR LOCATION, PHOSPHORYLATION AT THR-21. |
| [20] | "The crystal structure of the complex of replication protein A subunits RPA32 and RPA14 reveals a mechanism for single-stranded DNA binding." Bochkarev A., Bochkareva E., Frappier L., Edwards A.M. EMBO J. 18:4498-4504(1999) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 43-171 IN COMPLEX WITH RPA1 AND RPA3. |
| [21] | "Structural basis for the recognition of DNA repair proteins UNG2, XPA, and RAD52 by replication factor RPA." Mer G., Bochkarev A., Gupta R., Bochkareva E., Frappier L., Ingles C.J., Edwards A.M., Chazin W.J. Cell 103:449-456(2000) [PubMed] [Europe PMC] [Abstract] Cited for: STRUCTURE BY NMR OF 172-270. |
| [22] | "Structure of the RPA trimerization core and its role in the multistep DNA-binding mechanism of RPA." Bochkareva E., Korolev S., Lees-Miller S.P., Bochkarev A. EMBO J. 21:1855-1863(2002) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 44-171. |
| + | Additional computationally mapped references. |
Web resources
Cross-references
Sequence databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | J05249 mRNA. Translation: AAA36560.1. CR450348 mRNA. Translation: CAG29344.1. DQ001128 Genomic DNA. Translation: AAX84514.1. AL109927 Genomic DNA. Translation: CAI21777.1. AL109927 Genomic DNA. Translation: CAI21778.1. AL109927 Genomic DNA. Translation: CAI21775.1. BC001630 mRNA. Translation: AAH01630.1. BC012157 mRNA. Translation: AAH12157.1. BC021257 mRNA. Translation: AAH21257.1. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| IPI | IPI00013939. IPI00646500. IPI00647667. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PIR | A43711. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RefSeq | NP_002937.1. NM_002946.3. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| UniGene | Hs.79411. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ProteinModelPortal | P15927. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DIP | DIP-24187N. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| IntAct | P15927. 42 interactions. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| MINT | MINT-5002459. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| STRING | 9606.ENSP00000363021. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PhosphoSite | P15927. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Polymorphism databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DMDM | 132474. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PaxDb | P15927. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PRIDE | P15927. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DNASU | 6118. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Ensembl | ENST00000313433; ENSP00000363015; ENSG00000117748. ENST00000373909; ENSP00000363017; ENSG00000117748. ENST00000373912; ENSP00000363021; ENSG00000117748. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| GeneID | 6118. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| KEGG | hsa:6118. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| UCSC | uc001bpe.1. human. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CTD | 6118. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| GeneCards | GC01M028218. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HGNC | HGNC:10290. RPA2. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HPA | CAB016538. HPA026306. HPA026309. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| MIM | 179836. gene. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| neXtProt | NX_P15927. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PharmGKB | PA34652. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| eggNOG | COG5235. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOGENOM | HOG000216562. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOVERGEN | HBG000086. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| KO | K10739. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| OMA | GGNSFMP. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| OrthoDB | EOG4WQ13T. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PhylomeDB | P15927. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reactome | REACT_111183. Meiosis. REACT_115566. Cell Cycle. REACT_21300. Mitotic M-M/G1 phases. REACT_216. DNA Repair. REACT_383. DNA Replication. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ArrayExpress | P15927. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Bgee | P15927. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CleanEx | HS_RPA2. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Genevestigator | P15927. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| GermOnline | ENSG00000117748. Homo sapiens. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Gene3D | 1.10.10.10. 1 hit. 2.40.50.140. 1 hit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| InterPro | IPR012340. NA-bd_OB-fold. IPR004365. NA-bd_OB_tRNA-helicase. IPR014646. RPA32. IPR014892. RPA_C. IPR011991. WHTH_DNA-bd_dom. [Graphical view] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Pfam | PF08784. RPA_C. 1 hit. PF01336. tRNA_anti. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PIRSF | PIRSF036949. RPA32. 1 hit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SUPFAM | SSF50249. Nucleic_acid_OB. 1 hit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ChiTaRS | RPA2. human. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EvolutionaryTrace | P15927. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| GenomeRNAi | 6118. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| NextBio | 23759. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Entry information
| Entry name | RFA2_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P15927 Secondary accession number(s): Q52II0, Q5TEI9, Q5TEJ5 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 1 Human chromosome 1: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |

Clusters with
